Futura Medical plc (FAMDF)
OTCMKTS
· Delayed Price · Currency is USD
0.380
0.00 (0.00%)
Dec 24, 2024, 4:00 PM EST
Futura Medical Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 8.4 | 3.1 | - | - | - | 0.03 | Upgrade
|
| Revenue Growth (YoY) | 393.01% | - | - | - | - | - | Upgrade
|
| Cost of Revenue | 2.71 | 1.33 | - | - | - | - | Upgrade
|
| Gross Profit | 5.69 | 1.77 | - | - | - | 0.03 | Upgrade
|
| Selling, General & Admin | 8.04 | 6.69 | 2.74 | 2.09 | 1 | 1.14 | Upgrade
|
| Research & Development | 1.84 | 2.05 | 4.13 | 3.77 | 1.93 | 10.05 | Upgrade
|
| Operating Expenses | 9.87 | 8.74 | 6.87 | 5.87 | 2.93 | 11.2 | Upgrade
|
| Operating Income | -4.18 | -6.96 | -6.87 | -5.87 | -2.93 | -11.16 | Upgrade
|
| Interest & Investment Income | 0.12 | 0.07 | - | - | 0 | 0.02 | Upgrade
|
| Pretax Income | -4.07 | -6.89 | -6.87 | -5.87 | -2.93 | -11.14 | Upgrade
|
| Income Tax Expense | -0.31 | -0.38 | -1.02 | -0.91 | -0.52 | -2.22 | Upgrade
|
| Net Income | -3.75 | -6.51 | -5.85 | -4.96 | -2.41 | -8.92 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | -0 | - | Upgrade
|
| Net Income to Common | -3.75 | -6.51 | -5.85 | -4.96 | -2.41 | -8.92 | Upgrade
|
| Shares Outstanding (Basic) | 301 | 295 | 287 | 271 | 244 | 205 | Upgrade
|
| Shares Outstanding (Diluted) | 301 | 295 | 287 | 271 | 244 | 205 | Upgrade
|
| Shares Change (YoY) | 4.46% | 2.59% | 6.06% | 11.21% | 19.09% | 55.12% | Upgrade
|
| EPS (Basic) | -0.01 | -0.02 | -0.02 | -0.02 | -0.01 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.02 | -0.02 | -0.02 | -0.01 | -0.04 | Upgrade
|
| Free Cash Flow | -4.22 | -0.94 | -6.52 | -4.29 | -4.55 | -6.69 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.02 | -0.02 | -0.02 | -0.03 | Upgrade
|
| Gross Margin | 67.70% | 57.22% | - | - | - | 100.00% | Upgrade
|
| Operating Margin | -49.83% | -224.57% | - | - | - | -35130.49% | Upgrade
|
| Profit Margin | -44.68% | -210.03% | - | - | - | -28067.50% | Upgrade
|
| Free Cash Flow Margin | -50.20% | -30.17% | - | - | - | -21049.10% | Upgrade
|
| EBITDA | -4.06 | -6.83 | -6.85 | -5.85 | -2.9 | -11.14 | Upgrade
|
| EBITDA Margin | -48.35% | -220.37% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.12 | 0.13 | 0.02 | 0.02 | 0.03 | 0.02 | Upgrade
|
| EBIT | -4.18 | -6.96 | -6.87 | -5.87 | -2.93 | -11.16 | Upgrade
|
| EBIT Margin | -49.83% | -224.57% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.